AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
54 hedge funds and large institutions have $29.6M invested in AVEO Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
Holders
54
Holding in Top 10
2
Calls
$132K
Puts
$124K
Top Buyers
1 | +$2.76M | |
2 | +$1.47M | |
3 | +$1.04M | |
4 |
Morgan Stanley
New York
|
+$254K |
5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$218K |
Top Sellers
1 | -$861K | |
2 | -$583K | |
3 | -$447K | |
4 |
SIM
Spark Investment Management
New York
|
-$370K |
5 |
Goldman Sachs
New York
|
-$207K |